Cargando…
Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
In the oncological area, pancreatic cancer is one of the most lethal diseases, with 5-year survival rising just 10% in high-development countries. This disease is genetically characterized by KRAS as a driven mutation followed by SMAD4, CDKN2, and TP53-associated mutations. In clinical aspects, panc...
Autores principales: | Marin, Anelis Maria, Batista, Michel, Korte de Azevedo, Alexandre Luiz, Bombardelli Gomig, Talita Helen, Soares Caldeira Brant, Rodrigo, Chammas, Roger, Uno, Miyuki, Dias Araújo, Diogo, Zanette, Dalila Luciola, Nóbrega Aoki, Mateus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454563/ https://www.ncbi.nlm.nih.gov/pubmed/37628784 http://dx.doi.org/10.3390/ijms241612604 |
Ejemplares similares
-
Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients
por: Marin, Anelis Maria, et al.
Publicado: (2022) -
Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023) -
Susceptibility loci for pancreatic cancer in the Brazilian population
por: Aoki, Mateus Nóbrega, et al.
Publicado: (2021) -
Molecular BCR::ABL1 Quantification and ABL1 Mutation Detection as Essential Tools for the Clinical Management of Chronic Myeloid Leukemia Patients: Results from a Brazilian Single-Center Study
por: Marin, Anelis Maria, et al.
Publicado: (2023) -
Essential properties and pitfalls of colorimetric Reverse Transcription Loop-mediated Isothermal Amplification as a point-of-care test for SARS-CoV-2 diagnosis
por: de Oliveira Coelho, Bruna, et al.
Publicado: (2021)